Stephan Epinette Power - 03 Mar 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Reporting relationship: VP GM International
Issuer ticker: CNMD
Reported as of: 03 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 May 2025, 09:59:45 UTC
Prior SEC filing: 15 May 2025
Source filing: View source filing
Reporting owner signature: /s/Thomas Fistek for Stephan Epinette by Power of Attorney

Key filing fact

Stephan Epinette Power filed Form 4 for CONMED Corp (CNMD) on 15 May 2025.

Key facts

This page summarizes Stephan Epinette Power's Form 4 filing for CONMED Corp (CNMD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 May 2025, 09:59.

Change

Previous filing in this sequence was filed on 15 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001507941 Primary reporting owner

Epinette Stephan

Relationship: VP GM International
Address: C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO
Signature: /s/Thomas Fistek for Stephan Epinette by Power of Attorney
Signature date: 13 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNMD transaction Derivative

RSUs (Restricted Stock Units)

Award

Transaction value: $0
Shares: +17,144
Change %
Price: $0.000000
Shares after: 17,144
Date: 03 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,144
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in a four year period with zero (0) shares vesting in 2026; 8,572 shares vesting on 3/3/27; 6,429 shares vesting on 3/3/28 and 2,143 vesting on 3/3/29.